Annual Operating Profit
-$100.83 M
-$30.47 M-43.31%
31 December 2023
Summary:
Viking Therapeutics annual operaing income is currently -$100.83 million, with the most recent change of -$30.47 million (-43.31%) on 31 December 2023. During the last 3 years, it has fallen by -$58.16 million (-136.34%). VKTX annual operating profit is now -99629.97% below its all-time high of -$101.10 thousand, reached on 31 December 2013.VKTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$36.56 M
-$2.50 M-7.35%
30 September 2024
Summary:
Viking Therapeutics quarterly operating income is currently -$36.56 million, with the most recent change of -$2.50 million (-7.35%) on 30 September 2024. Over the past year, it has dropped by -$9.29 million (-34.08%). VKTX quarterly operating profit is now -1142275.00% below its all-time high of -$3200.00, reached on 31 March 2013.VKTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$133.97 M
-$9.29 M-7.45%
30 September 2024
Summary:
Viking Therapeutics TTM operating income is currently -$133.97 million, with the most recent change of -$9.29 million (-7.45%) on 30 September 2024. Over the past year, it has dropped by -$42.14 million (-45.89%). VKTX TTM operating profit is now -122133.58% below its all-time high of -$109.60 thousand, reached on 31 December 2012.VKTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VKTX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.3% | -34.1% | -45.9% |
| 3 y3 years | -136.3% | -172.7% | -146.1% |
| 5 y5 years | -285.4% | -391.4% | -334.2% |
VKTX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -136.3% | at low | -192.2% | at low | -146.1% | at low |
| 5 y | 5 years | -285.4% | at low | -391.4% | at low | -334.2% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
Viking Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$36.56 M(+7.3%) | -$133.97 M(+7.5%) |
| June 2024 | - | -$34.05 M(-0.1%) | -$124.68 M(+9.0%) |
| Mar 2024 | - | -$34.07 M(+16.3%) | -$114.36 M(+13.4%) |
| Dec 2023 | -$100.83 M(+43.3%) | -$29.29 M(+7.4%) | -$100.83 M(+9.8%) |
| Sept 2023 | - | -$27.27 M(+14.8%) | -$91.83 M(+13.7%) |
| June 2023 | - | -$23.74 M(+15.6%) | -$80.76 M(+8.2%) |
| Mar 2023 | - | -$20.54 M(+1.3%) | -$74.65 M(+6.1%) |
| Dec 2022 | -$70.36 M(+26.4%) | -$20.28 M(+25.2%) | -$70.36 M(+12.4%) |
| Sept 2022 | - | -$16.20 M(-8.1%) | -$62.58 M(+4.7%) |
| June 2022 | - | -$17.63 M(+8.5%) | -$59.79 M(+3.6%) |
| Mar 2022 | - | -$16.25 M(+29.9%) | -$57.70 M(+3.6%) |
| Dec 2021 | -$55.68 M(+30.5%) | -$12.51 M(-6.7%) | -$55.68 M(+2.3%) |
| Sept 2021 | - | -$13.40 M(-13.8%) | -$54.44 M(+7.0%) |
| June 2021 | - | -$15.54 M(+9.2%) | -$50.88 M(+10.7%) |
| Mar 2021 | - | -$14.23 M(+26.3%) | -$45.94 M(+7.7%) |
| Dec 2020 | -$42.66 M(+30.5%) | -$11.27 M(+14.5%) | -$42.66 M(+5.9%) |
| Sept 2020 | - | -$9.84 M(-7.2%) | -$40.27 M(+6.3%) |
| June 2020 | - | -$10.61 M(-3.1%) | -$37.87 M(+2.8%) |
| Mar 2020 | - | -$10.95 M(+23.4%) | -$36.83 M(+12.7%) |
| Dec 2019 | -$32.69 M(+24.9%) | -$8.87 M(+19.3%) | -$32.69 M(+6.0%) |
| Sept 2019 | - | -$7.44 M(-22.3%) | -$30.85 M(+0.1%) |
| June 2019 | - | -$9.57 M(+40.6%) | -$30.81 M(+9.4%) |
| Mar 2019 | - | -$6.81 M(-3.3%) | -$28.16 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$26.16 M(+37.2%) | -$7.04 M(-4.8%) | -$26.16 M(+11.1%) |
| Sept 2018 | - | -$7.39 M(+6.8%) | -$23.55 M(+13.0%) |
| June 2018 | - | -$6.92 M(+44.1%) | -$20.85 M(+10.3%) |
| Mar 2018 | - | -$4.80 M(+8.5%) | -$18.91 M(-0.9%) |
| Dec 2017 | -$19.07 M(+37.7%) | -$4.43 M(-5.6%) | -$19.07 M(+3.8%) |
| Sept 2017 | - | -$4.69 M(-5.8%) | -$18.38 M(+8.4%) |
| June 2017 | - | -$4.98 M(+0.3%) | -$16.95 M(+9.0%) |
| Mar 2017 | - | -$4.97 M(+32.9%) | -$15.55 M(+12.3%) |
| Dec 2016 | -$13.85 M(+15.4%) | -$3.74 M(+14.5%) | -$13.85 M(-6.0%) |
| Sept 2016 | - | -$3.26 M(-8.8%) | -$14.73 M(-6.5%) |
| June 2016 | - | -$3.58 M(+9.5%) | -$15.75 M(+6.4%) |
| Mar 2016 | - | -$3.27 M(-29.3%) | -$14.80 M(+23.4%) |
| Dec 2015 | -$12.00 M(-48.9%) | -$4.62 M(+7.7%) | -$12.00 M(+55.2%) |
| Sept 2015 | - | -$4.29 M(+63.2%) | -$7.73 M(+68.4%) |
| June 2015 | - | -$2.63 M(+469.8%) | -$4.59 M(-80.6%) |
| Mar 2015 | - | -$461.00 K(+30.4%) | -$23.72 M(+1.1%) |
| Dec 2014 | -$23.47 M(>+9900.0%) | -$353.60 K(-69.2%) | -$23.47 M(+1.5%) |
| Sept 2014 | - | -$1.15 M(-94.7%) | -$23.11 M(+5.2%) |
| June 2014 | - | -$21.76 M(>+9900.0%) | -$21.97 M(+9589.1%) |
| Mar 2014 | - | -$209.70 K(+1133.5%) | -$226.70 K(+74.7%) |
| Dec 2013 | -$101.10 K | - | - |
| June 2013 | - | -$17.00 K(+431.3%) | -$129.80 K(+15.1%) |
| Mar 2013 | - | -$3200.00(-97.1%) | -$112.80 K(+2.9%) |
| Dec 2012 | - | -$109.60 K | -$109.60 K |
FAQ
- What is Viking Therapeutics annual operaing income?
- What is the all time high annual operating profit for Viking Therapeutics?
- What is Viking Therapeutics annual operating profit year-on-year change?
- What is Viking Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Viking Therapeutics?
- What is Viking Therapeutics quarterly operating profit year-on-year change?
- What is Viking Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Viking Therapeutics?
- What is Viking Therapeutics TTM operating profit year-on-year change?
What is Viking Therapeutics annual operaing income?
The current annual operating profit of VKTX is -$100.83 M
What is the all time high annual operating profit for Viking Therapeutics?
Viking Therapeutics all-time high annual operaing income is -$101.10 K
What is Viking Therapeutics annual operating profit year-on-year change?
Over the past year, VKTX annual operaing income has changed by -$30.47 M (-43.31%)
What is Viking Therapeutics quarterly operating income?
The current quarterly operating profit of VKTX is -$36.56 M
What is the all time high quarterly operating profit for Viking Therapeutics?
Viking Therapeutics all-time high quarterly operating income is -$3200.00
What is Viking Therapeutics quarterly operating profit year-on-year change?
Over the past year, VKTX quarterly operating income has changed by -$9.29 M (-34.08%)
What is Viking Therapeutics TTM operating income?
The current TTM operating profit of VKTX is -$133.97 M
What is the all time high TTM operating profit for Viking Therapeutics?
Viking Therapeutics all-time high TTM operating income is -$109.60 K
What is Viking Therapeutics TTM operating profit year-on-year change?
Over the past year, VKTX TTM operating income has changed by -$42.14 M (-45.89%)